Heistein LC et al. |
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. |
2008 |
Pediatr Cardiol |
pmid:17896127
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Patrignani P et al. |
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. |
2008 |
Pharmacogenet. Genomics |
pmid:18551041
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Geske FJ et al. |
AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect. |
2008 |
Mol Diagn Ther |
pmid:18288882
|
Roethig HJ et al. |
A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. |
2008 |
J Clin Pharmacol |
pmid:18319361
|
Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|
Bruce EC et al. |
Platelet thromboxane A2 secretion in patients with major depression responsive to electroconvulsive therapy. |
2008 |
Psychosom Med |
pmid:18378867
|
Ciabattoni G et al. |
Determinants of platelet activation in Alzheimer's disease. |
2007 |
Neurobiol. Aging |
pmid:16442186
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Schwartz JI et al. |
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. |
2007 |
J Clin Pharmacol |
pmid:17925592
|
Baltzer WI et al. |
Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. |
2006 |
Am. J. Vet. Res. |
pmid:16426215
|
Faraday N et al. |
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. |
2006 |
Am. J. Cardiol. |
pmid:16950183
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Laleman W et al. |
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. |
2006 |
Eur. J. Clin. Invest. |
pmid:16620286
|
Ohmori T et al. |
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. |
2006 |
J. Thromb. Haemost. |
pmid:16706971
|
Santilli F et al. |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16412866
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|